Skip to content
  • Home
  • Blog
  • Resources
  • Contact
  • About us
  • Position statement on open access
Open Pharma

Open Pharma

  • Home
  • Blog
  • Resources
  • Contact
  • About us
  • Position statement on open access

Author: sarahsabir

June 25, 2020July 2, 2020 sarahsabir Guest Posts

Ways to increase transparency, trust and patient involvement in pharma-funded publications – insights from the virtual 16th Annual Meeting of ISMPP

This year, the Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) went virtual. With a mix of engaging live and recorded sessions, 15 roundtables and over 45 posters to delve into, we share some of the highlights from the meeting.

Share this:

  • Tweet
February 11, 2020 sarahsabir News, Open access

Combatting the next outbreak: why open access matters

As the Open Pharma position statement reaches over 100 endorsements, we share why open access is important for public health and hear why publishing house Frontiers has endorsed the position statement.

Share this:

  • Tweet
February 4, 2020March 17, 2020 sarahsabir News

The evolving role of medical publication professionals in improving the accessibility and discoverability of scientific research

Open Pharma Members, Supporters and key advisers came together to discuss how medical publication professionals can improve the accessibility and discoverability of scientific research.

Share this:

  • Tweet
November 7, 2019 sarahsabir Open access

Reflecting on the release of the Open Pharma position statement on open access

Today, just over two weeks from the launch of the Open Pharma position statement on open access, we reflect on how the statement came about, the benefits it offers to different types of stakeholders and the success it has had so far.

Share this:

  • Tweet
September 20, 2019 sarahsabir News

Weekly digest: what’s happening in open science?

Featuring news from Peer Review Week, help for smaller scientific societies with the transition to Plan S and recommendations by NIH to make data more FAIR

Share this:

  • Tweet
July 12, 2019 sarahsabir News

Weekly digest: what’s happening in open science?

Featuring the latest results from the Good Pharma Scorecard, the newest signatories to DORA, incentives for sharing data and potential barriers to mandating open access.

Share this:

  • Tweet
May 24, 2019 sarahsabir News

Weekly digest: what’s happening in open science?

Featuring the development of a new evidence framework for discussing hot open science topics that can be used to address misinformation in scientific publishing, the introduction of transparent manuscript-handling processes, and making the costs of clinical trials publicly available.

Share this:

  • Tweet
May 17, 2019 sarahsabir News

Weekly digest: what’s happening in open science?

Featuring the benefits of open data, why the public should be involved in scientific research and countries that are leading the way in open access publishing.

Share this:

  • Tweet
March 5, 2019March 5, 2019 sarahsabir Layered publication models, Open access, Resources

Using metadata to make open access science discoverable

In January 2019, Open Pharma core members and supporters attended a roundtable meeting, hosted by The BMJ at its Head Office at BMA House in London.

Share this:

  • Tweet

Subscribe

Join 367 other subscribers

Find content related to…

Follow us on Twitter

My Tweets

Search

Social

  • View _openpharma’s profile on Twitter